Oncolytics Biotech (ONCY) Divestments (2009 - 2010)

Oncolytics Biotech's (ONCY) quarterly Divestments came in at -$1.9 million in Q3 2010, down 146212.3% year-on-year from N/an in Q3 2009, and down 4764.72% on a QoQ basis from -$39851.0 in Q2 2010.

Oncolytics Biotech (ONCY) Divestments (2009 - 2010) Analysis & Trends

Oncolytics Biotech (ONCY) has 2 years of Divestments data on file, last reported at -$1.9 million in Q3 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -32.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Oncolytics Biotech 372.40 Mn 372.40 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2010 -1.94 Mn
Jun 30, 2010 -39,851.00
Sep 30, 2009 -1,325.00
Jun 30, 2009 1.93 Mn